SEC Comment Letter for TRANSENTERIX, INC. (TRXDW) (CIK 0000876378) — Feb 11, 2020
TRANSENTERIX, INC. (TRXDW) (CIK 0000876378)
Date: Feb. 11, 2020 · CIK: 0000876378 · Accession: 0000000000-20-001245
AI Filing Summary & Sentiment
File numbers found in text: 333-236200
Letter
February 7, 2020 Anthony Fernando Chief Executive Officer Transenterix, Inc. 635 Davis Drive, Suite 300 Morrisville, NC 27560 Re:Transenterix, Inc. Registration Statement on Form S-3 Filed January 31, 2020 File No. 333-236200 Dear Mr. Fernando: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary Mullany, Esq.
Show Raw Text
February 7, 2020
Anthony Fernando
Chief Executive Officer
Transenterix, Inc.
635 Davis Drive, Suite 300
Morrisville, NC 27560
Re:Transenterix, Inc.
Registration Statement on Form S-3
Filed January 31, 2020
File No. 333-236200
Dear Mr. Fernando:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary Mullany, Esq.